Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA120721 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Gene expression profile of ascites cell samples from patients with advanced ovarian cancer
| PRJNA121559 | ENA
Project description:Prediction of progression-free survival in patients with advanced-stage serous ovarian cancer
| PRJNA118945 | ENA
Project description:microRNA alterations associated to early relapse in advanced stage ovarian cancer patients (validation set)
| PRJNA280993 | ENA
Project description:microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (training set)
| PRJNA142789 | ENA
Project description:microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (test set)
| PRJNA142791 | ENA
Project description:RNA extracted at 240min. Samples are rRNA depleted. Expression measurement of Homo sapiens genes.
2019-07-31 | GSE114179 | GEO
Project description:The Japanese Serous Ovarian Cancer Study Group Advanced-stage ovarian cancer is one of the most lethal gynecologic malignancies. To improve prognosis of patients with ovarian cancers, a predictive biomarkers leading to personalized treatments are required. In this large-scale cross-platform study of six microarray datasets consisting of 1054 ovarian cancer patients, we developed a novel risk classification system based on a 126-gene expression signature for predicting overall survival by applying elastic net7 and 10-fold cross validation to a Japanese dataset A (n = 260). We further validated its predictive ability with the five other datasets using multivariate analysis. Also, through gene ontology and pathway analyses of 1109 high-risk ovarian cancer specific transcripts, we identified a significant reduction of expression of immune-response related genes, especially on the antigen presentation pathway. Furthermore, an immunohistochemical analysis demonstrated that the number of CD8 T lymphocytes infiltrating into tumor tissue was significantly decreased in high-risk ovarian cancers. These predictive biomarkers based on the 126-gene expression signature will identify high-risk ovarian cancer patients who need novel immune-activating therapeutic approaches, leading to improved outcomes for such patients. Two hundred sixty patients who were diagnosed as advanced-stage high-grade serous ovarian cancer were analyzed in this study. Microaray data from 10 patients who were diagnosed as advanced-stage high-grade serous ovarian cancer were analyzed to investigate coefficient of correlation in each probes between Agilent Whole Human Genome Oligo Microarray and Affymetrix HG-U133Plus2.0.
2012-03-01 | E-GEOD-32062 | biostudies-arrayexpress
Project description:Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
| PRJNA148341 | ENA
Project description:Gene expression profiling of immortalized human mesenchymal stem cells with hTERT/E6/E7 transfected MSCs. hTERT may change gene expression in MSCs. Goal was to determine the gene expressions of immortalized MSCs.
2010-09-25 | GSE24338 | GEO